Gyre Therapeutics (GYRE) Net Margin Growth (3y) (2013 - 2026)
Gyre Therapeutics (GYRE) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,253.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
506.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Gyre Therapeutics |
554.75 Mn |
540.62 Mn |
8.38 Mn |
-4,759.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-4,759.00 |
| Dec 31, 2025 |
2,484.00 |
| Mar 31, 2025 |
184,296.00 |
| Dec 31, 2024 |
83,198.00 |
| Sep 30, 2024 |
110,219.00 |
| Jun 30, 2024 |
177,441.00 |
| Mar 31, 2024 |
155,724.00 |
| Dec 31, 2023 |
55,886.00 |
| Sep 30, 2023 |
180,782.00 |
| Jun 30, 2023 |
104,661.00 |
| Mar 31, 2023 |
3,377.00 |
| Mar 31, 2021 |
8.25 Mn |
| Dec 31, 2020 |
87,820.00 |
| Sep 30, 2020 |
2,629.00 |
| Jun 30, 2020 |
781,376.00 |
| Mar 31, 2020 |
150,217.00 |
| Mar 31, 2018 |
-8.30 Mn |
| Dec 31, 2017 |
-113,114.00 |
| Sep 30, 2017 |
-93,322.00 |
| Jun 30, 2017 |
-611,466.00 |
